Drug Shortage Report for PRIORIX-TETRA
Report ID | 137979 |
Drug Identification Number | 02297884 |
Brand name | PRIORIX-TETRA |
Common or Proper name | Combined measles, mumps, rubella and varicella vaccine, live, attenuated |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | MUMPS VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED RUBELLA VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED |
Strength(s) | 25118.9CCID50 1000CCID50 1000CCID50 1995.2623CCID50 |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 10s |
ATC code | J07BD |
ATC description | VIRAL VACCINES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-04-20 |
Estimated end date | 2021-07-26 |
Actual end date | 2021-07-20 |
Shortage status | Resolved |
Updated date | 2021-07-21 |
Company comments | Supply unavailable |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-07-21 | English | Compare |
v8 | 2021-07-20 | French | Compare |
v7 | 2021-07-20 | English | Compare |
v6 | 2021-07-16 | French | Compare |
v5 | 2021-07-16 | English | Compare |
v4 | 2021-04-28 | French | Compare |
v3 | 2021-04-28 | English | Compare |
v2 | 2021-04-23 | French | Compare |
v1 | 2021-04-23 | English | Compare |
Showing 1 to 9 of 9